151 Allosteric MEK inhibitor BAY 86-9766 (RDEA119) shows anti-tumor efficacy in mono-and combination therapy in preclinical models of hepatocellular carcinoma and pancreatic cancer

✍ Scribed by F. Puehler; A. Scholz; M. Kissel; A. Adjei; J.N. Miner; M. Hitchcock; R. Schmieder; D. Mumberg; K. Ziegelbauer

• Book ID: 119602832
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 46 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)71856-5